Cargando…
New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box(®) that present synergism with itraconazole
BACKGROUND: Black fungi of the Herpotrichiellaceae family are agents of chromoblastomycosis and phaeohyphomycosis. There are few therapeutic options for these infections and it is common to associate antifungal drugs in their treatment. OBJECTIVES: To investigate the Medicines for Malaria Venture (M...
Autores principales: | Coelho, Rowena Alves, Alves, Gabriela Machado, Figueiredo-Carvalho, Maria Helena Galdino, Almeida-Silva, Fernando, de Souza, Gabriela Rodrigues, Lourenço, Maria Cristina da Silva, Brito-Santos, Fábio, Amaral, Ana Claudia Fernandes, Almeida-Paes, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467274/ https://www.ncbi.nlm.nih.gov/pubmed/36102413 http://dx.doi.org/10.1590/0074-02760220089 |
Ejemplares similares
-
A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis
por: Coelho, Rowena Alves, et al.
Publicado: (2020) -
Repurposing Benzimidazoles against Causative Agents of Chromoblastomycosis: Albendazole Has Superior In Vitro Activity Than Mebendazole and Thiabendazole
por: Coelho, Rowena Alves, et al.
Publicado: (2023) -
Cutaneous Phaeohyphomycosis Caused by Alternaria alternata Unresponsive to Itraconazole Treatment
por: Gomes, Joana, et al.
Publicado: (2011) -
Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil
por: Coelho, Rowena Alves, et al.
Publicado: (2018) -
Chromoblastomycosis: tissue modifications during itraconazole
treatment
por: Purim, Kátia Sheylla Malta, et al.
Publicado: (2017)